New NAC members dedicated to solving the ‘puzzles’ of PI
Primary immunodeficiency can bring other immune system diagnoses
Volunteer established PI education groups 33 years ago
Ask the expert: PI and travel
Mavorixafor approved for treating WHIM syndrome
Insurers block immunoglobulin access using multiple tactics
Immunoglobulin product booklet
Xolremdi
Mavorixafor.
Approved to treat: Warts, hypogammaglobulinemia, immunodeficiency, myelokathexis (WHIM) syndrome.
Ages: 12+
Report side effects/adverse events at 1-866-MED-X4MI (1-866-633-9464).